Literature DB >> 10051599

Adhesion to fibronectin stimulates proliferation of wild-type and bcr/abl-transfected murine hematopoietic cells.

A Krämer1, S Hörner, A Willer, S Fruehauf, A Hochhaus, M Hallek, R Hehlmann.   

Abstract

Cells of most tissues require adhesion to a surface to grow. However, for hematopoietic cells, both stimulation and inhibition of proliferation by adhesion to extracellular matrix components have been described. Furthermore, it has been suggested that progenitor cells from chronic myelogenous leukemia show decreased beta1 integrin-mediated adhesion to fibronectin, resulting in increased proliferation and abnormal trafficking. However, we show here that the chronic myelogenous leukemia-specific fusion protein p210bcr/abl stimulates the expression of alpha5beta1 integrins and induces adhesion to fibronectin when expressed in the myeloid cell line 32D. Moreover, proliferation of both p210bcr/abl-transfected 32D (32Dp210) cells and untransfected 32D cells is stimulated by immobilized fibronectin. Cell cycle analysis revealed that nonadherent 32D and 32Dp210 cells are arrested in late G1 or early S phase, whereas the adherent fractions continue cycling. Although both adherent and nonadherent p210bcr/abl-transfected and parental 32D cells express equal amounts of cyclin A, a protein necessary for cell cycle progression at the G1/S boundary, cyclin A complexes immunoprecipitated from 32D cells cultured on immobilized fibronectin were found to be catalytically inactive in nonadherent but not in adherent cells. In addition, as compared with untransfected 32D cells, cyclin A immunoprecipitates from 32Dp210 cells exhibited a greatly elevated kinase activity and remained partially active irrespective of the adhesion status. The lack of cyclin A/cyclin-dependent kinase (CDK) 2 activity in nonadherent 32D cells appeared to result from increased expression and cyclin A complex formation of the CDK inhibitor p27(Kip1). Taken together, our results indicate that adhesion stimulates cell cycle progression of hematopoietic cells by down-regulation of p27(Kip1), resulting in activation of cyclin A/CDK2 complexes and subsequent transition through the G1/S adhesion checkpoint.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051599      PMCID: PMC26741          DOI: 10.1073/pnas.96.5.2087

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

Review 1.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

2.  Dependence of cyclin E-CDK2 kinase activity on cell anchorage.

Authors:  F Fang; G Orend; N Watanabe; T Hunter; E Ruoslahti
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

3.  Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation.

Authors:  R W Hurley; J B McCarthy; C M Verfaillie
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  A novel CCAAT-binding protein necessary for adhesion-dependent cyclin A transcription at the G1/S boundary is sequestered by a retinoblastoma-like protein in G0.

Authors:  A Krämer; C P Carstens; W E Fahl
Journal:  J Biol Chem       Date:  1996-03-22       Impact factor: 5.157

5.  Activation-dependent alpha5beta1 integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells.

Authors:  B I Lundell; J B McCarthy; N L Kovach; C M Verfaillie
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

6.  Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1.

Authors:  D Resnitzky; L Hengst; S I Reed
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

7.  Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia.

Authors:  R Bhatia; J B McCarthy; C M Verfaillie
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

8.  The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation.

Authors:  M W Renshaw; J R McWhirter; J Y Wang
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

9.  Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.

Authors:  X Zhu; M Ohtsubo; R M Böhmer; J M Roberts; R K Assoian
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

10.  Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins.

Authors:  J P Lévesque; D I Leavesley; S Niutta; M Vadas; P J Simmons
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more
  11 in total

1.  Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia.

Authors:  Mio Yamamoto-Sugitani; Junya Kuroda; Eishi Ashihara; Hisao Nagoshi; Tsutomu Kobayashi; Yosuke Matsumoto; Nana Sasaki; Yuji Shimura; Miki Kiyota; Ryuko Nakayama; Kenichi Akaji; Tomohiko Taki; Nobuhiko Uoshima; Yutaka Kobayashi; Shigeo Horiike; Taira Maekawa; Masafumi Taniwaki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

2.  Covalent immobilization of stem cell factor and stromal derived factor 1α for in vitro culture of hematopoietic progenitor cells.

Authors:  Maude L Cuchiara; Kelsey L Horter; Omar A Banda; Jennifer L West
Journal:  Acta Biomater       Date:  2013-08-17       Impact factor: 8.947

3.  Bcr-Abl induces abnormal cytoskeleton remodeling, beta1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathway.

Authors:  Yingzhu Li; Nancy Clough; Xiaolin Sun; Weidong Yu; Brian L Abbott; Christopher J Hogan; Zonghan Dai
Journal:  J Cell Sci       Date:  2007-03-27       Impact factor: 5.285

Review 4.  Molecular biology of chronic myeloid leukemia.

Authors:  Y Maru
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

5.  Effects of the tyrosine kinase inhibitor imatinib mesylate on a Bcr-Abl-positive cell line: suppression of autonomous cell growth but no effect on decreased adhesive property and morphological changes.

Authors:  Toshio Nishihara; Yasuo Miura; Yumi Tohyama; Chisato Mizutani; Terutoshi Hishita; Satoshi Ichiyama; Takashi Uchiyama; Kaoru Tohyama
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

6.  Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.

Authors:  Anupriya Agarwal; Thomas G P Bumm; Amie S Corbin; Thomas O'Hare; Marc Loriaux; Jonathan VanDyke; Stephanie G Willis; Jutta Deininger; Keiichi I Nakayama; Brian J Druker; Michael W Deininger
Journal:  Blood       Date:  2008-06-17       Impact factor: 22.113

7.  Ti-6Al-7Nb promotes cell spreading and fibronectin and osteopontin synthesis in osteoblast-like cells.

Authors:  Thanaphum Osathanon; Kritchai Bespinyowong; Mansuang Arksornnukit; Hidekazu Takahashi; Prasit Pavasant
Journal:  J Mater Sci Mater Med       Date:  2006-07       Impact factor: 4.727

8.  Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibition.

Authors:  Ellen L Weisberg; Martin Sattler; Abdel Kareem Azab; Dirk Eulberg; Anna Kruschinski; Paul W Manley; Richard Stone; James D Griffin
Journal:  Oncotarget       Date:  2017-11-06

9.  Regulation of hematopoietic stem cell behavior by the nanostructured presentation of extracellular matrix components.

Authors:  Christine Anna Muth; Carolin Steinl; Gerd Klein; Cornelia Lee-Thedieck
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  A comparative analysis of the in vitro effects of pulsed electromagnetic field treatment on osteogenic differentiation of two different mesenchymal cell lineages.

Authors:  Gabriele Ceccarelli; Nora Bloise; Melissa Mantelli; Giulia Gastaldi; Lorenzo Fassina; Maria Gabriella Cusella De Angelis; Davide Ferrari; Marcello Imbriani; Livia Visai
Journal:  Biores Open Access       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.